500,0
+0,00%
2026-10-16
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +79.8% | +27.3% | 2 / 3 | -40.7% | +99.94 pp | +291.02 pp | +1.9% | -0.57 | — | 17,3 | −40,7% | −26,0 | +79,8% | — | -0.09 | — |
| Pts | 12 | 4 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 500,0 (close price on 2026-10-16)EPS (TTM): −5.164,7
Financial charts
1.Revenue & growth
VND bn17,3Q2/26
1.Revenue & growth
VND bn17,3Q2/26
2.Profit & growth
VND bn-28,0Q2/26
3.Profit mix (Penman)
VND bn-103Q2/26
4.Margins & cost structure
%-66.5%Q2/26
5.Returns & cash cycle
% · days1.9%Q2/26
6.Earnings quality & cash
VND bn22,3Q2/26
7.Asset structure
VND bn98,5Q2/26
8.Funding & debt health
VND bn · times98,5Q2/26
9.Revenue backlog
VND bn13,4Q2/26
10.Valuation
times · %-0,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-1.396Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26